铁亡及其目前在胃癌中的进展
Zhenqi Yue1,2, Yiwu Yuan1,2, Qi Zhou1,2
1Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Frontiers in cell and developmental biology
|March 14, 2024
概括
铁亡是一种明显的细胞死亡途径,显著影响胃癌 (GC) 的进展,转移和耐药性. 向铁灭症为GC治疗策略提供了一个有希望的新途径.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 胃癌 (GC) 是全球领先的恶性瘤,预后不佳,转移潜力高.
- 铁亡是一种受调节的细胞死亡形式,与亡和亡不同.
- 新出现的证据将铁灭与GC增殖,转移,耐药性和微环境调节联系起来.
研究的目的:
- 审查铁灭症的潜在机制.
- 阐明铁死在胃癌发育和进展中的作用.
- 探索ferroptosis诱导在GC治疗中的潜力.
主要方法:
- 关于铁亡机制的文献综述.
- 对研究胃癌中铁亡的研究进行分析.
- 在GC中诱导ferroptosis的抗瘤药物数据的汇编.
主要成果:
- 铁生影响关键的GC过程,包括扩散和转移.
- 各种抗癌药物已经证明能够在GC细胞中诱导铁亡.
- 铁灭的调节为GC提供了一个新的治疗策略.
结论:
- 铁亡是胃癌发病的一个关键因素.
- 向铁化具有显著的治疗潜力,可以改善GC患者的治疗结果.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K